Search Results 121-130 of 13566 for isotretinoin

  1. Clinical trials - Oncology (Medical)

    ... isotretinoin; B) current COG recommended high-risk therapy with the addition of a block of 131I-MIBG after the third Induction cycle; or C) current COG ...

  2. Clinical trials - Oncology (Medical)

    ... isotretinoin; B) current COG recommended high-risk therapy with the addition of a block of 131I-MIBG after the third Induction cycle; or C) current COG ...

  3. A Study Of Pomalidomide, Ixazomib Citrate, And Dexamethasone In Treating Patients With Previously Treated Multiple Myeloma Or Plasma Cell Leukemia - Mayo Clinic

    Biological therapies, such as pomalidomide, and dexamethasone, use substances made from living organisms that may stimulate or suppress the immune system in ...

  4. Clinical trials - Oncology (Medical)

    ... isotretinoin; B) current COG recommended high-risk therapy with the addition of a block of 131I-MIBG after the third Induction cycle; or C) current COG ...

  5. Pityriasis rosea - Symptoms & causes - Mayo Clinic

    Examples include terbinafine, isotretinoin, omeprazole, gold, arsenic and barbiturates. Complications. Complications of pityriasis rosea aren't likely. If ...

  6. Clinical trials - Oncology (Medical)

    ... isotretinoin; B) current COG recommended high-risk therapy with the addition of a block of 131I-MIBG after the third Induction cycle; or C) current COG ...

  7. Osimertinib (oral route) - Side effects & dosage - Mayo Clinic

    Osimertinib is used to treat non-small cell lung cancer (NSCLC) in patients who have certain types of abnormal epidermal growth factor (EGFR) genes. This ...

  8. Resorcinol and sulfur (topical route) - Mayo Clinic

    This medicine is available without a prescription. This product is available in the following dosage forms: Lotion; Cream. Back to top ...

  9. Cancer Clinical Trials - Medical Professionals - Mayo Clinic

    ... isotretinoin; B) current COG recommended high-risk therapy with the addition of a block of 131I-MIBG after the third Induction cycle; or C) current COG ...

  10. Clinical trials - Oncology (Medical)

    ... isotretinoin; B) current COG recommended high-risk therapy with the addition of a block of 131I-MIBG after the third Induction cycle; or C) current COG ...